( February 5, 2026, 11:16 AM EST) -- NEWARK, N.J. — A New Jersey federal judge ruled that a complaint filed against a company that purports to sell compounded semaglutide for weight loss can continue after finding that the maker of the drugs approved by the U.S. Food and Drug Administration showed injury and that its claims are not preempted....